Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 3-spirocyclic piperidine derivatives as ghrelin receptor agonists

3-spirocyclic piperidine derivatives as ghrelin receptor agonists

US Patent 8546416 · Granted Oct 1, 2013

Estimated economic value: $9,976,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of mPTP2025
Covalent targeting of E3 ligases2024
Hydroquinazoline derivatives for the treatment of a disease or disorder2024
2-azaspiro[3.4]octane derivatives as M4 agonists2024
2-azaspiro[3.4]octane derivatives as M4 agonists2023
Meta tyrosine derivatives as rho-kinase inhibitors2023
Carboxamide derivatives2023
Enzyme inhibitors2023
2-azaspiro[3.4]octane derivatives as M4 agonists2023
2-azaspiro[3.4]octane derivatives as M4 agonists2022
Tyrosine analogues derivatives as Rho-kinase inhibitors2021
Locked nucleic acid cyclic dinucleotide compounds and uses thereof2021